Latest Varian Medical Systems Stories
BARCELONA, Spain, May 11, 2012 /PRNewswire/ -- European cancer experts have reported their progress with promising new radiosurgical techniques for treating cancer and other conditions using new linear accelerator technology from Varian Medical Systems (NYSE: VAR). Speakers at Varian's Emerging Technologies Symposium at the annual ESTRO conference detailed their experiences with fast hypo-fractionated treatments for prostate patients and RapidArc® Radiosurgery for intracranial and...
SEOUL, Korea, May 9, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) will showcase a new user interface for the company's ProBeam(TM) proton therapy system at the upcoming annual meeting of the Particle Therapy Co-Operative Group (PTCOG 51) here, May 14-19. The new interface streamlines the steps for imaging, positioning and treating patients with image-guided intensity-modulated proton therapy (IMPT). The new user interface for Varian's ProBeam system is based on...
BARCELONA, Spain, May 8, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE:VAR), the world leader in radiotherapy, is demonstrating its full range of disease specific treatment options at the 31st meeting of the European Society for Radiotherapy and Oncology here in Barcelona this week. As this year's meeting is combined with the annual World Congress of Brachytherapy, Varian's booth will also focus strongly on the company's leading range of brachytherapy equipment and...
LAS VEGAS, May 1, 2012 /PRNewswire/ -- Noninvasive stereotactic ablative radiotherapy (SABR), a technical term for radiosurgery in the body, can be a viable option for treating operable cases of early-stage lung cancer, with outcomes that compare favorably to more invasive surgery, according to a study published in the May 2012 issue of the International Journal of Radiation Oncology, Biology, Physics.[1] Speaking at a symposium sponsored by Varian...
PALO ALTO, Calif., April 26, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) announced today that its management will hold a mid-year review for investors from 11:30 a.m. through 1:30 p.m. on May 7, 2012 at the Intercontinental Times Square, 300 W. 44(th) St., New York. Management presentations will cover financial performance through the first half of fiscal year 2012, strategic initiatives, and growth opportunities in markets for oncology systems, x-ray imaging, and...
PALO ALTO, Calif., April 25, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) today is reporting results for the second quarter of fiscal year 2012 with net earnings of $0.94 per diluted share up 9 percent from $0.86 per diluted share in the second quarter of fiscal year 2011. The results for the second quarter of fiscal year 2012 include a $2.5 million or $0.02 per diluted share restructuring charge associated with realigning resources to address growth prospects in emerging...
PALO ALTO, Calif., April 25, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) and Siemens Healthcare today announced the signing of a strategic global partnership to provide advanced diagnostic and therapeutic solutions and services for treating cancer with image-guided radiotherapy and radiosurgery. The collaboration covers the mutual marketing and representation of products for imaging and treatment in the global radiation oncology business. This collaboration further...
NEW YORK, April 18, 2012 /PRNewswire/ -- Varian Medical Systems' ground-breaking TrueBeam(TM) system for radiation treatments is making itself known outside the medical profession, as the company begins an advertising campaign in The New York Times Magazine next week with the succinct, yet powerful, message to "Make cancer the victim." The two-page print ads were the first created by the newly opened San Diego office of the New York advertising agency DeVito/Verdi. DeVito/Verdi...
MIAMI BEACH, Fla., April 12, 2012 /PRNewswire/ -- Leading experts in radiosurgery of the spine will present information about how to treat spinal tumors effectively using stereotactic radiosurgery rather than invasive surgical procedures during the annual meeting of the American Association of Neurological Surgeons (AANS) here later this week. New techniques in image-guided radiosurgical treatment of benign and malignant spinal lesions will be the focus of a special workshop for...
DURBAN, South Africa, April 12, 2012 /PRNewswire/ -- Fast RapidArc® radiotherapy treatments for cancer patients have captured the attention and interest of leading clinicians who have begun offering it in Africa. Clinicians from across Africa attended a week-long workshop sponsored here by Varian Medical Systems (NYSE: VAR) where image-guided RapidArc IMRT technology was the focus of discussion. Doctors and decision makers from South Africa, Zimbabwe, Namibia, Kenya and Angola...
